Image

Global In-Vivo Imaging Market – Industry Trends and Forecast to 2030

Healthcare

Image

Global In-Vivo Imaging Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global In-Vivo Imaging Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 896.72 USD Million
Diagram Market Size (Forecast Year) USD 1,459.71 USD Million
Diagram CAGR %

Major Markets Players

  • PerkinElmer
  • Bruker
  • FUJIFILM Holdings America Corporation
  • Siemens
  • Miltenyi Biotec

Global In-Vivo Imaging Market, By Modality (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging Systems, Magnetic Particle Imaging Systems), Reagents (Optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents, CT Contrast Agents), Techniques (Radioisotopes Based, Biomarkers Based, Luminescent Proteins Based, Others), End User (Hospitals and Clinics, Imaging Centers, Research Organizations, Others) – Industry Trends and Forecast to 2030.

In-Vivo Imaging Market

In-Vivo Imaging Market Analysis and Size

Rapid technological advancement in molecular imaging is one of the key factors expected to accelerate the growth and demand for In-vivo imaging. Furthermore, an increase in public-private initiatives and high funding to support preclinical research are expected to contribute to the global market's growth from 2023 to 2030. The rapid rise in demand for noninvasive small-animal imaging techniques and rapid advancements in healthcare services and technology are also expected to boost market growth. Furthermore, an increase in awareness of the benefits of early disease detection and an increase in the rate of clinical acceptance of multi-modality imaging systems are important factors.

Data Bridge Market Research analyses that the In-vivo imaging market which was USD 896.716 million in 2022, is expected to reach USD 1459.71 million by 2030, at a CAGR of 6.28% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

In-Vivo Imaging Market Scope and Segmentation  

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Modality (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging Systems, Magnetic Particle Imaging Systems), Reagents (Optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents, CT Contrast Agents), Techniques (Radioisotopes Based, Biomarkers Based, Luminescent Proteins Based, Others), End User (Hospitals and Clinics, Imaging Centers, Research Organizations, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

PerkinElmer Inc. (U.S.), Bruker (U.S.), FUJIFILM Holdings America Corporation (Canada), Siemens (Germany), Miltenyi Biotec (Germany), CMR Naviscan (U.S.), SCANCO Medical AG (Switzerland), Aspect Imaging Ltd. (Israel), Mediso Ltd. (U.S.), LI-COR, Inc. (U.S.), Takara Bio Inc. (Japan), MILabs B.V. (Netherlands), MR Solutions (U.K.), Trifoil Imaging (U.S.), Biospace Lab (France), Koninklijke Philips N.V (Netherlands), General Electric (U.S.), Hitachi, Ltd. (Japan), and Guerbet (France)

Market Opportunities

  • Rising demand of In-vivo camera imaging

Market Definition

In vivo imaging is the visualization of various life processes within an organism. With one-touch, user-defined or pre-set PC controls for repeatable and precise imaging, an in vivo imaging system aids in mechanizing in vivo imaging research. Depending on the application, in vivo imaging systems can be used on both animals and humans. In research laboratories, in vivo imaging systems are typically used to study the activity of a drug on animals such as albino mice, albino rats, and so on. These small animal imaging procedures include a full body scan as well as a targeted scan. Full body scan is a popular imaging method because it is inexpensive and can thus be used for commercialization and regular validation of new drugs.

In-Vivo Imaging Market Dynamics

Drivers

  • Rise in preclinical imaging

Preclinical imaging (in-vivo) is used in live animal testing for drug discovery and preparation. Preclinical imaging is also used to monitor patient responses and detect early signs of efficacy. The development of in vivo imaging technologies has enabled quantitative analysis of disease at the molecular level. In vivo imaging connects in vitro exploratory and in vivo clinical testing, allowing direct and rapid transmission of preclinical findings from animal models to human clinical trials. The major disease fields addressed by in vivo preclinical imaging are neurological disorders, autoimmune conditions, cancers, and cardiovascular diseases. These are the certain factors which propel the market growth.

Opportunities

  • Rising demand of In-vivo camera imaging

In-vivo imaging is in high demand, particularly in research and development laboratories in fields such as biology, medicine, and chemistry. To study biological processes over time, traditional experiments necessitate the slaughter of a large number of animals at various times. In vivo camera imaging requires only a few specimens because the progression can be studied without sacrificing the animal. Furthermore, the accuracy of In-vivo imaging has been a major factor driving the global In-vivo imaging market.

Restraints/Challenges

  • High cost

The high cost of clinical and preclinical imaging systems, as well as low healthcare expenditures in developing countries, are expected to limit the growth of the In-vivo imaging market, while technological and procedural limitations, combined with standalone preclinical imaging systems, may pose a challenge to the market's growth.

This In-vivo imaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the In-vivo imaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global In-Vivo Imaging Market Scope

The In-vivo imaging market is segmented on the basis of modality, reagents, techniques and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Modality

  • Optical Imaging Systems
  • Bioluminescence/fluorescence imaging systems
  •  Standalone fluorescence imaging systems
  •  Optical + X-ray/optical + CT
  • Nuclear Imaging Systems
  • Micro-PET systems
  • Micro-SPECT systems
  • Trimodality (SPECT/PET/CT) systems
  • Micro-MRI
  • Micro-Ultrasound
  • Micro-CT
  • Photoacoustic Imaging Systems
  • Magnetic Particle Imaging Systems

 Reagents

  • Optical Imaging Reagents
  • Bioluminescent imaging reagents
  • Fluorescent imaging reagents
  • Nuclear Imaging Reagents
  • PET tracers and SPECT probes
  • MRI Contrast Agents
  • Gadolinium-based
  • Iron-based
  • Manganese-based
  • Ultrasound Contrast Agents
  • CT Contrast Agents
  • Iodine-based
  • Barium-based
  • Gold nanoparticles
  •                          Gastrografin-based

Techniques  

  • Radioisotopes Based
  • Biomarkers Based
  • Luminescent Proteins Based
  • Others

 End User

  • Hospitals and Clinics
  • Imaging Centers
  • Research Organizations
  • Others

In-Vivo Imaging Market Regional Analysis/Insights

The In-vivo imaging market is analyzed and market size insights and trends are provided by country, modality, reagents, techniques and end user as referenced above.

The countries covered in the In-vivo imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the In-vivo imaging market owing to the rise in prevalence of cancer and the strong presence of developed countries such as the U.S. and Canada.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of the high adoption of new technologies in the medical service sector in the developing economies such as India and China.                                                                                              

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The In-vivo imaging market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for In-vivo imaging market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the In-vivo imaging market. The data is available for historic period 2011-2021.

Competitive Landscape and In-Vivo Imaging Market Share Analysis

The In-vivo imaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to In-vivo imaging market.

Some of the major players operating in the In-vivo imaging market are:

  • PerkinElmer Inc. (U.S.)
  • Bruker (U.S.)
  • FUJIFILM Holdings America Corporation (Canada)
  • Siemens (Germany)
  • Miltenyi Biotec (Germany)
  • CMR Naviscan (U.S.)
  • SCANCO Medical AG (Switzerland)
  • Aspect Imaging Ltd. (Israel)
  • Mediso Ltd. (U.S.)
  • LI-COR, Inc. (U.S.)
  • Takara Bio Inc. (Japan)
  • MILabs B.V. (Netherlands)
  • MR Solutions (U.K.)
  • Trifoil Imaging (U.S.)
  • Biospace Lab (France)
  • Koninklijke Philips N.V (Netherlands)
  • General Electric (U.S.)
  • Hitachi, Ltd. (Japan)
  • Guerbet (France)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The In-Vivo Imaging Market is projected to grow at a CAGR of 6.28% during the forecast period by 2030.
The future market value of the In-Vivo Imaging Market is expected to reach USD 1459.71 million by 2030.
The major players in the In-Vivo Imaging Market are PerkinElmer Inc. (U.S.), Bruker (U.S.), FUJIFILM Holdings America Corporation (Canada), Siemens (Germany), Miltenyi Biotec (Germany), CMR Naviscan (U.S.), SCANCO Medical AG (Switzerland), etc.
The countries covered in the In-vivo imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials